Mohammad Eslami
Overview
Explore the profile of Mohammad Eslami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi M, Luo Y, Tian Y, Shen L, Zebardast N, Eslami M, et al.
NPJ Digit Med
. 2025 Jan;
8(1):46.
PMID: 39833503
Glaucoma is the leading cause of irreversible blindness globally. Research indicates a disproportionate impact of glaucoma on racial and ethnic minorities. Existing deep learning models for glaucoma detection might not...
2.
Hanifi S, Dekamin M, Eslami M
Sci Rep
. 2024 Sep;
14(1):22201.
PMID: 39333595
In this research, magnetic bismuth ferrite nanoparticles (BFO MNPs) were prepared through a convenient method and characterized. The structure and morphological characteristics of the prepared nanomaterial were confirmed through analyses...
3.
Shi M, Lokhande A, Tian Y, Luo Y, Eslami M, Kazeminasab S, et al.
Transl Vis Sci Technol
. 2024 Aug;
13(8):11.
PMID: 39110574
Purpose: To predict 10-2 Humphrey visual fields (VFs) from 24-2 VFs and associated non-total deviation features using deep learning. Methods: We included 5189 reliable 24-2 and 10-2 VF pairs from...
4.
Ghanegolmohammadi F, Eslami M, Ohya Y
Comput Struct Biotechnol J
. 2024 Aug;
23:2949-2962.
PMID: 39104709
Quantitative morphological phenotyping (QMP) is an image-based method used to capture morphological features at both the cellular and population level. Its interdisciplinary nature, spanning from data collection to result analysis...
5.
Jarosinski M, Kennedy J, Iyer S, Tzeng E, Eslami M, Sridharan N, et al.
Ann Vasc Surg
. 2024 Jul;
110(Pt B):224-235.
PMID: 39067849
Background: Acute limb ischemia (ALI) is a morbid and deadly diagnosis. However, existing epidemiologic studies describing ALI predate the introduction of the Affordable Care Act in 2010 and direct oral...
6.
Shobeiri P, Bahri R, Khadembashiri M, Khadembashiri M, Maleki S, Eslami M, et al.
Cancer Rep (Hoboken)
. 2024 Mar;
7(3):e2029.
PMID: 38517409
Background: Cholangiocarcinoma (CCA), as a rare malignancy of the biliary tree, has a poor prognosis most of the time. CCA is highly epigenetically regulated and several long non-coding RNAs (lncRNA)...
7.
Radkhah H, Esfandbod M, Khadembashiri M, Eslami M, Etesam F, Shahi F, et al.
J Community Hosp Intern Med Perspect
. 2024 Mar;
14(1):18-24.
PMID: 38482077
Introduction: Chemotherapeutic agents have the potential to induce neurotoxicity, resulting in a range of symptoms, including mild paresthesia, neuropathic pain, pronounced ataxia, and significant impairment. Taxane-induced neuropathy (TIN) is a...
8.
Zangiabadian M, Sharifian Ardestani M, Rezaee M, Saberi Sharbabaki E, Nikoohemmat M, Eslami M, et al.
Health Sci Rep
. 2024 Feb;
7(2):e1888.
PMID: 38357482
Background And Aims: Fragmented QRS (fQRS), which is associated with rhythm disturbances, can predispose the heart to fatal ventricular arrhythmias. Recently, accumulating studies indicates that fQRS is associated with poor...
9.
Jarosinski M, Kennedy J, Khamzina Y, Alie-Cusson F, Tzeng E, Eslami M, et al.
J Vasc Surg
. 2024 Jan;
79(5):1151-1162.e3.
PMID: 38224861
Background: Acute limb ischemia (ALI) carries a 15% to 20% risk of combined death or amputation at 30 days and 50% to 60% at 1 year. Percutaneous mechanical thrombectomy (PT)...
10.
SeyedAlinaghi S, Afsahi A, Shahidi R, Afzalian A, Mirzapour P, Eslami M, et al.
SAGE Open Med
. 2023 Nov;
11:20503121231208273.
PMID: 38020797
Objectives: Stigmatization was reported throughout the COVID pandemic for COVID-19 patients and close contacts. The aim of this systematic review was to comprehensively examine the prevalence and impact of stigmatization...